Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Abraham

Showing results (861-870 of 953) with videos related to

Pageof 96
Sort By:
Respiratory Research|August 7, 2013
Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung diseaseGisela E Lindahl, Carmel Jw Stock, Xu Shi-Wen, et al.
Cell|November 24, 2014
CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancerEdmond Chipumuro, Eugenio Marco, Camilla L Christensen, et al.
Cancer Cell|January 24, 2018
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing SarcomaAmanda Balboni Iniguez, Björn Stolte, Emily Jue Wang, et al.
Cancer Treatment Reviews|March 16, 2023
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in CanadaJason K Wong, Howard J Lim, Vincent C Tam, et al.
AIDS Research and Human Retroviruses|July 24, 2012
The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT InfectionMeropi Aravantinou, Rachel Singer, Nina Derby, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
The Journal of Rheumatology|February 5, 2013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosisAngelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, et al.
The Journal of Rheumatology|April 17, 2018
Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb TrialMark C Genovese, César Pacheco-Tena, Arturo Covarrubias, et al.
Cell|September 26, 2015
CDK7-dependent transcriptional addiction in triple-negative breast cancerYubao Wang, Tinghu Zhang, Nicholas Kwiatkowski, et al.
Nature Communications|June 2, 2017
Corrigendum: Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.
Pageof 96

Showing results (861-870 of 953) with videos related to

Sort By:
Pageof 96
Respiratory Research|August 7, 2013
Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung diseaseGisela E Lindahl, Carmel Jw Stock, Xu Shi-Wen, et al.
Cell|November 24, 2014
CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancerEdmond Chipumuro, Eugenio Marco, Camilla L Christensen, et al.
Cancer Cell|January 24, 2018
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing SarcomaAmanda Balboni Iniguez, Björn Stolte, Emily Jue Wang, et al.
Cancer Treatment Reviews|March 16, 2023
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in CanadaJason K Wong, Howard J Lim, Vincent C Tam, et al.
AIDS Research and Human Retroviruses|July 24, 2012
The nonnucleoside reverse transcription inhibitor MIV-160 delivered from an intravaginal ring, but not from a carrageenan gel, protects against simian/human immunodeficiency virus-RT InfectionMeropi Aravantinou, Rachel Singer, Nina Derby, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
The Journal of Rheumatology|February 5, 2013
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosisAngelo De Lauretis, Piersante Sestini, Panagiotis Pantelidis, et al.
The Journal of Rheumatology|April 17, 2018
Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb TrialMark C Genovese, César Pacheco-Tena, Arturo Covarrubias, et al.
Cell|September 26, 2015
CDK7-dependent transcriptional addiction in triple-negative breast cancerYubao Wang, Tinghu Zhang, Nicholas Kwiatkowski, et al.
Nature Communications|June 2, 2017
Corrigendum: Small genomic insertions form enhancers that misregulate oncogenesBrian J Abraham, Denes Hnisz, Abraham S Weintraub, et al.
Pageof 96